SEC Form 4 · accession 0001104659-16-110420
Aralez Pharmaceuticals Inc. · ARLZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Inc/bc Qlt
10% Owner
Period of report
Mar 17, 2016
Accepted (ET)
Apr 7, 2016 · 9:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001660719
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares | Mar 17, 2016 | S | 2,400,000 | $6.25 | D | 4,800,000 | D |
Table II — derivative securities
No Table II lines on this filing.